53
Views
3
CrossRef citations to date
0
Altmetric
Original Article: Clinical

The ratio between CD4 + and CD8 + cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomide

, , , , , , , & show all
Pages 999-1006 | Received 21 Jan 2005, Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Philipp Schütt, Dieter Brandhorst, Werner Stellberg, Miriam Poser, Peter Ebeling, Siemke Müller, Ulrike Buttkereit, Bertram Opalka, Monika Lindemann, Hans Grosse-Wilde, Siegfried Seeber, Thomas Moritz & Mohammad R. Nowrousian. (2006) Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections. Leukemia & Lymphoma 47:8, pages 1570-1582.
Read now

Articles from other publishers (2)

Pa-Fan Hsiao, Cheng-Hsiang Hsiao, Tsen-Fang Tsai, Ming Yao & Shiou-Hwa Jee. (2009) Granulomatous Slack Skin Presenting as Acquired Ichthyosis and Muscle Masses. American Journal of Clinical Dermatology 10:1, pages 29-32.
Crossref
Deborah A. Thomas, Francis J. Giles, Maher Albitar, Jorge E. Cortes, Srdan Verstovsek, Stefan Faderl, Susan M. O'Brien, Guillermo Garcia-Manero, Michael J. Keating, Sherry Pierce, Jerome Zeldis & Hagop M. Kantarjian. (2006) Thalidomide therapy for myelofibrosis with myeloid metaplasia. Cancer 106:9, pages 1974-1984.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.